Innate Pharma SA - SPONSORED ADS (IPHA)

CUSIP: 45781K204

Q3 2026 13F Holders as of 30 Sep 2026

Share change
-11
SEC-reported price per share
$1.63
Number of holders
3
Value change
-$18
Number of sells
1

Security key

45781K204

Report period

Q3 2026

Institutions

3

Top holders

3

Ownership snapshot

Top reported holders of IPHA - Innate Pharma SA - SPONSORED ADS (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Sanofi
Disclosed value leader
Lion Point Capital, LP
Comparable rows
3/13
Latest evidence
30 Jun 2026
13D/G 13F Lead comparable stake: 9% 10 rows are not safely comparable across share classes. 13D/G row: Sanofi Showing 1-6 of 13 holder rows.

Quick read

Sanofi leads the comparable SEC ownership view at 9%.

3 of 13 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Sanofi's linked filing trail.
Comparable ownership Top 3
Sanofi 9%
ASTRAZENECA PLC 8.3%
Bpifrance Participations SA 7.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 13 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Sanofi
13D/G
9%
Reported 13D/G · 23 Apr 2025
—
8,345,387 shares
$0 23 Apr 2025
ASTRAZENECA PLC
13D/G
8.3%
Reported 13D/G · 22 Dec 2025
—
7,825,501 shares
$0 22 Dec 2025
Bpifrance Participations SA
13D/G
Caisse des depots et consignations
7.9%
Reported 13D/G · 25 Apr 2025
—
7,319,429 shares
$0 25 Apr 2025
Lion Point Capital, LP
13F
Company
13F
—
denominator unverified
$149,318
81,151 shares
— 30 Jun 2026
MORGAN STANLEY
13F
Company
13F
—
denominator unverified
$80,084
43,524 shares
— 30 Jun 2026
SmartHarvest Portfolios, LLC
13F
Company
13F
—
denominator unverified
$43,700
23,750 shares
— 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
3
Shares
20,887
Rows available
3
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
10
Q3 2026 holders
3
Holder diff
-7
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .